Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Alberto Alvarez-Larran, Arturo Pereira, Paola Guglielmelli, Juan Carlos Hernandez-Boluda, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marin, Alimam Samah, Martin Griesshammer, Ana Kerguelen, Bjorn Andreasson, Carmen Burgaleta, Jiri Schwarz, Valentin Garcia-Gutierrez, Rosa Ayala, Pere Barba, Maria Teresa Gomez-Casares, Chiara Paoli, Beatrice Drexler, Sonja Zweegman, Mary F. McMullinJan Samuelsson, Claire Harrison, Francisco Cervantes, Alessandro M. Vannucchi, Carlos Besses

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)926-931
JournalHaematologica
Volume101
Issue number8
DOIs
Publication statusPublished - Aug 2016

Cite this

Alvarez-Larran, A., Pereira, A., Guglielmelli, P., Carlos Hernandez-Boluda, J., Arellano-Rodrigo, E., Ferrer-Marin, F., ... Besses, C. (2016). Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation. Haematologica, 101(8), 926-931. https://doi.org/10.3324/haematol.2016.146654